BIOMEDevice San Jose is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BIOMEDigital 2020 Session Viewer

Welcome to the BIOMEDigital session viewer. Browse and sort the growing list of sessions by day or track. All sessions are shown in Eastern Time.

Recent FDA Biocompatibility Feedback From 510k Submissions

Thor Rollins  (Director, Toxicology and E&L Consulting, Nelson Labs, LLC)

Location: Conference Track: Digital Health

Date: Wednesday, November 4

Time: 1:00 pm - 2:00 pm

Track: Conference: Digital Health

Vault Recording: TBD

Submitting for an approval for a medical device through the FDA can be a stressful and anxious time. It is important to understand the most recent recommendations from the agency. Too often these recommendations are given through feedback from the submission process itself, making a proactive approach difficult. In this presentation we will review recent FDA suggestions from real 510k submissions. These suggestions will touch on all aspects of the ISO 10993 standard series from cytotoxicity, sample preparation, E&L, toxicology, and more.

From this presentation, audience members will learn:

• Which biocompatibility topics is the FDA most focused on?
• What points are important to include in our extractable and leachable testing?
• How should you set up your sample preparation?
• What concerns to address in your biocompatibility testing before you start the tests?

The Advanced Manufacturing Technology Series Asia • North America • South America Learn More »